Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Aug;60(2):216–219. doi: 10.1038/bjc.1989.254

Colony forming ability of human breast carcinomas: lack of prognostic significance.

L Ottestad 1, K M Tveit 1, E Hannisdal 1, M Skrede 1, J M Nesland 1, S Gundersen 1, A Pihl 1
PMCID: PMC2247049  PMID: 2765368

Abstract

To study whether colony growth in vitro reflects the prognosis of breast cancer patients, specimens from a total number of 138 patients with primary breast carcinomas were cultivated in the Courtenay-Mills soft agar method. The plating efficiency (PE) values were related to various clinical and histopathological parameters. No significant correlation was found between colony forming ability and menopausal status, histopathology, TNM-status or steroid hormone receptor status. The crude survival of the patients was not significantly correlated to the in vitro growth of the tumours; neither was there any difference in relapse-free survival between patients whose tumours failed to grow in vitro and those having growing tumours (PE greater than 0). A multivariate survival analysis of 115 patients with primary tumours without distant metastases revealed that the PE was not a significant independent prognostic indicator, as it gave no additional prognostic information above that of node and ER status. It is concluded that routine measurement of colony formation in vitro is not warranted in the management of breast cancer.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aapro M. S., Eliason J. F., Krauer F., Alberto P. Colony formation in vitro as a prognostic indicator for primary breast cancer. J Clin Oncol. 1987 Jun;5(6):890–896. doi: 10.1200/JCO.1987.5.6.890. [DOI] [PubMed] [Google Scholar]
  2. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  3. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dittrich C., Jakesz R., Wrba F., Havelec L., Haas O., Spona J., Holzner H., Kolb R., Moser K. The human tumour cloning assay in the management of breast cancer patients. Br J Cancer. 1985 Aug;52(2):197–203. doi: 10.1038/bjc.1985.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dressler L. G., Seamer L. C., Owens M. A., Clark G. M., McGuire W. L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer. 1988 Feb 1;61(3):420–427. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  6. Elashoff J. D. Surviving proportional hazards. Hepatology. 1983 Nov-Dec;3(6):1031–1035. doi: 10.1002/hep.1840030623. [DOI] [PubMed] [Google Scholar]
  7. Fisher B., Slack N. H., Bross I. D. Cancer of the breast: size of neoplasm and prognosis. Cancer. 1969 Nov;24(5):1071–1080. doi: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  9. Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. doi: 10.1002/1097-0142(197908)44:2<671::aid-cncr2820440238>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  10. Kallioniemi O. P., Blanco G., Alavaikko M., Hietanen T., Mattila J., Lauslahti K., Lehtinen M., Koivula T. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer. 1988 Nov 15;62(10):2183–2190. doi: 10.1002/1097-0142(19881115)62:10<2183::aid-cncr2820621019>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  11. Meyer J. S., McDivitt R. W., Stone K. R., Prey M. U., Bauer W. C. Practical breast carcinoma cell kinetics: review and update. Breast Cancer Res Treat. 1984;4(2):79–88. doi: 10.1007/BF01806389. [DOI] [PubMed] [Google Scholar]
  12. Nemoto T., Vana J., Bedwani R. N., Baker H. W., McGregor F. H., Murphy G. P. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980 Jun 15;45(12):2917–2924. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  13. Silvestrini R., Daidone M. G., Gasparini G. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer. 1985 Oct 15;56(8):1982–1987. doi: 10.1002/1097-0142(19851015)56:8<1982::aid-cncr2820560816>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  14. Singletary S. E., Umbach G. E., Spitzer G., Drewinko B., Tomasovic B., Ajani J., Hug V., Blumenschein G. The human tumor stem cell assay revisited. Int J Cell Cloning. 1985 Mar;3(2):116–128. doi: 10.1002/stem.5530030205. [DOI] [PubMed] [Google Scholar]
  15. Sutherland C. M., Mather F. J., Carter R. D., Cerise E. J., Krementz E. T. Breast cancer as analyzed by the human tumor stem cell assay. Surgery. 1983 Aug;94(2):370–375. [PubMed] [Google Scholar]
  16. Tubiana M., Pejovic M. H., Chavaudra N., Contesso G., Malaise E. P. The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer. 1984 Apr 15;33(4):441–445. doi: 10.1002/ijc.2910330404. [DOI] [PubMed] [Google Scholar]
  17. Tveit K. M., Fodstad O., Olsnes S., Pihl A. In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity. Int J Cancer. 1980 Dec 15;26(6):717–722. doi: 10.1002/ijc.2910260604. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES